Moderna’s norovirus vaccine enters Phase III trials in the UK
There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.
World-first vaccine for vomiting bug norovirus trialled in the UK
The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.
UK’s first norovirus mRNA vaccine trial launched
The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and safety of a norovirus vaccine called mRNA-1403.
Norovirus vaccine to be trialled in the UK in world-first
A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.
Vaccine for winter vomiting bug to be trialled on thousands
A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards,
World’s first vaccine for winter vomiting bug norovirus to be trialled in UK
A vaccine to guard against the winter vomiting bug norovirus is set for a year-long groundbreaking NHS trial after early results showed it creates a “strong immune response”. It is hoped an effective norovirus vaccine,
UK testing ‘world-first’ vaccine for winter vomiting bug, aiming to curb burden on health system
The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna. View on euronews
Moderna, Inc. (MRNA): Leading the Way in mRNA Vaccines and Respiratory Health
We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...
The Daily Northwestern1d
Northwestern files lawsuit against Moderna, seeks royalties for COVID mRNA vaccine technology
Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...
clinicaltrialsarena2d
IDWeek 2024: Moderna’s norovirus vaccine mRNA-1403 shows potential in Phase I/II trial
At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...
Norovirus vaccine: Everything we know about jab that could end winter vomiting bug for good
It is hoped the new norovirus jab could help lift the burden on the NHS over the busy winter months - here we explain who is ...
Updated COVID vaccine approved : Who needs it, where to get it, and what it protects against?
The Ministry of Health has approved Moderna's updated COVID vaccines, which target the new JN1 variant of the virus.
Covid Vaccine Tech Is Being Used to Fight a Nasty, Diarrhea-Causing Bacteria
Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...
We Think Moderna Still Has A Future
Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...